| pubmed-article:10853668 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10853668 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:10853668 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:10853668 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:10853668 | lifeskim:mentions | umls-concept:C2267054 | lld:lifeskim |
| pubmed-article:10853668 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:10853668 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
| pubmed-article:10853668 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
| pubmed-article:10853668 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:10853668 | pubmed:dateCreated | 2000-11-15 | lld:pubmed |
| pubmed-article:10853668 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:abstractText | A series of indole and carbazole based inhibitors of factor Xa (FXa) has been investigated. The most potent compound inhibits FXa with a Ki of 0.2 nM and has 900- and 750-fold selectivity over thrombin and trypsin, respectively. | lld:pubmed |
| pubmed-article:10853668 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10853668 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10853668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10853668 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10853668 | pubmed:month | May | lld:pubmed |
| pubmed-article:10853668 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:10853668 | pubmed:author | pubmed-author:ShawK JKJ | lld:pubmed |
| pubmed-article:10853668 | pubmed:author | pubmed-author:LiangAA | lld:pubmed |
| pubmed-article:10853668 | pubmed:author | pubmed-author:ZhaoZZ | lld:pubmed |
| pubmed-article:10853668 | pubmed:author | pubmed-author:TrinkAA | lld:pubmed |
| pubmed-article:10853668 | pubmed:author | pubmed-author:KoovakkatS... | lld:pubmed |
| pubmed-article:10853668 | pubmed:author | pubmed-author:ArnaizD ODO | lld:pubmed |
| pubmed-article:10853668 | pubmed:author | pubmed-author:WitlowMM | lld:pubmed |
| pubmed-article:10853668 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10853668 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:10853668 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:10853668 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10853668 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10853668 | pubmed:pagination | 957-61 | lld:pubmed |
| pubmed-article:10853668 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:meshHeading | pubmed-meshheading:10853668... | lld:pubmed |
| pubmed-article:10853668 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10853668 | pubmed:articleTitle | Design, synthesis, and in vitro biological activity of indole-based factor Xa inhibitors. | lld:pubmed |
| pubmed-article:10853668 | pubmed:affiliation | Discovery Research, Berlex Biosciences, Richmond, CA 94804, USA. damian_arnaiz@berlex.com | lld:pubmed |
| pubmed-article:10853668 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:10853668 | lld:chembl |
